Preventing hepatitis B though universal vaccination: reduction of inequalities through the GAVI China project
- PMID: 24331017
- DOI: 10.1016/j.vaccine.2012.07.048
Preventing hepatitis B though universal vaccination: reduction of inequalities through the GAVI China project
Abstract
Objective: In order to measure hepatitis B coverage and progress in equality with respect to protection against hepatitis B in poverty-affected areas funded by the Global Alliance on Vaccine and Immunization project funded in poverty-affected counties.
Methods: We reviewed routinely reported coverage data and conducted a national stratified, validation, cross-sectional survey in October 2010, according to WHO recommended sampling method. First, we stratified China into three regions (Eastern, Central and Western) based on economic criteria. Second, in each region, we selected eight counties with a probability proportional to population size. Third, in each selected county, we selected (a) 10 townships at random among the list of townships of the county.
Results: We visited 244 townships as part of the final evaluation (71 in the East, 86 in the Center and 87 in the West). Overall, in these 244 townships, surveyed TBD coverage increased from 60% in 2002 to 91% in 2009 and surveyed three dose of hepatitis B vaccine coverage increased from 71% in 2002 to 93% in 2009. Overall, in the GAVI supported areas, the HepB3/DTP3 ratio increased from 57% in 2002 to 94% in 2009.
Conclusion: Pro-poor GAVI approach was an effective way to reduce inequity among children through provision of free vaccination. When vaccine and AD syringes were provided for free, they closed the gap between Eastern and Western regions and between the rich and the poor.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.Vaccine. 2013 Dec 27;31 Suppl 9:J36-42. doi: 10.1016/j.vaccine.2012.11.061. Vaccine. 2013. PMID: 24331019
-
The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.Vaccine. 2013 Dec 27;31 Suppl 9:J15-20. doi: 10.1016/j.vaccine.2013.03.045. Vaccine. 2013. PMID: 24331015 Review.
-
Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.Vaccine. 2013 Dec 27;31 Suppl 9:J73-8. doi: 10.1016/j.vaccine.2012.09.060. Vaccine. 2013. PMID: 24331024
-
Origins, design and implementation of the China GAVI project.Vaccine. 2013 Dec 27;31 Suppl 9:J8-14. doi: 10.1016/j.vaccine.2012.12.019. Vaccine. 2013. PMID: 24331025 Review.
-
Evaluation of immunization injection safety in China, 2010: achievements, future sustainability.Vaccine. 2013 Dec 27;31 Suppl 9:J43-8. doi: 10.1016/j.vaccine.2012.11.057. Vaccine. 2013. PMID: 24331020
Cited by
-
Using a hepatitis B surveillance system evaluation in Fujian, Hainan, and Gansu provinces to improve data quality and assess program effectiveness, China, 2015.BMC Infect Dis. 2020 Jul 25;20(1):547. doi: 10.1186/s12879-020-05265-3. BMC Infect Dis. 2020. PMID: 32711465 Free PMC article.
-
Spatial-temporal analysis of hepatitis B in Fujian Province, China in 2012-2021.Infect Med (Beijing). 2024 Apr 19;3(2):100110. doi: 10.1016/j.imj.2024.100110. eCollection 2024 Jun. Infect Med (Beijing). 2024. PMID: 38974348 Free PMC article.
-
Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings.World J Hepatol. 2022 Jul 27;14(7):1333-1343. doi: 10.4254/wjh.v14.i7.1333. World J Hepatol. 2022. PMID: 36158908 Free PMC article. Review.
-
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B.J Clin Transl Hepatol. 2019 Dec 28;7(4):322-328. doi: 10.14218/JCTH.2019.00052. Epub 2019 Dec 20. J Clin Transl Hepatol. 2019. PMID: 31915601 Free PMC article.
-
Hepatitis B At-Birth Dose Vaccine: An Urgent Call for Implementation in Ghana.Vaccines (Basel). 2018 Mar 12;6(1):15. doi: 10.3390/vaccines6010015. Vaccines (Basel). 2018. PMID: 29534503 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous